The Usefulness of SPECT/CT in Sentinel Node Mapping of Early Stage Breast Cancer Patients Showing Negative or Equivocal Findings on Planar Scintigraphy

Overview

Journal Asia Ocean J Nucl Med Biol

Specialty Nuclear Medicine

Date 2018 Jul 13

PMID 29998140

Citations 6

Authors

Maimoona Siddique

M Khalid Nawaz

Humayun Bashir

Affiliations

Soon will be listed here.

Abstract

Objectives: This study sought to determine the diagnostic yield of SPECT/CT in localizing axillary sentinel lymph nodes (SLNs) in early breast cancer patients where planar scintigraphy (PS) was equivocal or negative.

Methods: Prospective analysis of early stage breast cancer patients with non-palpable axillary nodes undergoing SLN localization prior to nodal sampling for axillary staging. PS findings were categorized as: Category A: non-visualization of SLN; Category B: unusual uptake location; Category C: equivocal uptake / difficult interpretation. The K-coefficient of Cohen was used to evaluate the correlation between PS and SPECT/CT results. PS and SPECT/CT images were interpreted separately, and SLN identification on each of the modalities was correlated to BMI (Body mass index) and peroperative radio guided results.

Results: Between April 2015 and January 2017, 1028 early breast cancer cases underwent sentinel lymphoscintigraphy. Of total, 134 (13%) patients underwent SPECT/CT in addition to PS. All were females with mean age of 48.15 years (range: 26-82 years). Right sided in 68, left in 64 and 2 with bilateral carcinoma. By TNM classification: 49 (37%) T, 78 (58%) T and 7 (5%) had DCIS/Paget's disease.Overall SLNs were detected on both PS and SPECT/CT in 60% cases. Of category A (n=54); 35/54 (64%) SLN localized on SPECT/CT; 32 were level-I; 2 Level-II; 1 Level-III nodes. In 19, SLN was not localized. Of category B (n=18), 5 had prior lumpectomy, SPECT/CT localized tracer uptake to 17 level-I sentinel nodes, 3 level-II and level III / IMC in 9. Of category C (n=62), 29 had prior lumpectomy. SPECT/CT confirmed SLN in all the cases. Radio-guided surgery confirmed SPECT/CT results. The correlation between the two techniques was low (K=0.34). Where PS was negative; SPECT/CT localized nodes in statistically significant number of cases (=0.01). PS identified SLN uptakes in 80/134 (60%) cases with a mean BMI of 21.6±4.8 kg/m while SPECT/CT detected ''hot'' nodes in 115/134 (86%) cases with a mean BMI of 29.6±5.6 kg/m. For overweight/obese patients (n=59) (BMI>25 kg/m), PS failed to identify SLNs in 49 and SPECT/CT failed to do so in 18 (<0.001).

Conclusion: SPECT/CT has diagnostic yield and helps in precise SLN localization where planar imaging is negative or shows unusual site of uptake.

Citing Articles

Sentinel Lymph Node Mapping in Breast Cancer: Initial Experience of a Multidisciplinary Team.

Yasmin T, Younis M, Masood M, Khan H, Asgher Z, Shahid A Cureus. 2022; 14(6):e25983.

PMID: 35859965 PMC: 9286901. DOI: 10.7759/cureus.25983.

Preoperative planar lymphoscintigraphy allows for sentinel lymph node detection in 51 dogs improving staging accuracy: Feasibility and pitfalls.

Manfredi M, De Zani D, Chiti L, Ferrari R, Stefanello D, Giudice C Vet Radiol Ultrasound. 2021; 62(5):602-609.

PMID: 34131982 PMC: 8518895. DOI: 10.1111/vru.12995.

Ultrasonographic Algorithm for the Assessment of Sentinel Lymph Nodes That Drain the Mammary Carcinomas in Female Dogs.

Stan F, Gudea A, Damian A, Gal A, Papuc I, Pop A Animals (Basel). 2020; 10(12).

PMID: 33321917 PMC: 7763578. DOI: 10.3390/ani10122366.

Evaluation of camera-based freehand SPECT in preoperative sentinel lymph node mapping for melanoma patients.

Kogler A, Polemi A, Nair S, Majewski S, Dengel L, Slingluff Jr C EJNMMI Res. 2020; 10(1):139.

PMID: 33175204 PMC: 7658290. DOI: 10.1186/s13550-020-00729-8.

99mTc-sestamibi SPECT/CT and 18F-FDG-PET/CT have similar performance but different imaging patterns in newly diagnosed multiple myeloma.

Mosci C, Pericole F, Oliveira G, Delamain M, Takahashi M, Carvalheira J Nucl Med Commun. 2020; 41(10):1081-1088.

PMID: 32732603 PMC: 7497601. DOI: 10.1097/MNM.0000000000001259.

References

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M . Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2014; 136(5):E359-86. DOI: 10.1002/ijc.29210. View

van der Ploeg I, Nieweg O, Kroon B, Rutgers E, Baas-Vrancken Peeters M, Vogel W . The yield of SPECT/CT for anatomical lymphatic mapping in patients with breast cancer. Eur J Nucl Med Mol Imaging. 2009; 36(6):903-9. DOI: 10.1007/s00259-008-1050-4. View

Dickinson R, Erwin W, Stevens D, Bidaut L, Mar M, Macapinlac H . Hybrid Modality Fusion of Planar Scintigrams and CT Topograms to Localize Sentinel Lymph Nodes in Breast Lymphoscintigraphy: Technical Description and Phantom Studies. Int J Mol Imaging. 2011; 2011:298102. PMC: 3065894. DOI: 10.1155/2011/298102. View

Law M, Ma W, Leung R, Li S, Wong K, Ho W . Evaluation of patient effective dose from sentinel lymph node lymphoscintigraphy in breast cancer: a phantom study with SPECT/CT and ICRP-103 recommendations. Eur J Radiol. 2012; 81(5):e717-20. DOI: 10.1016/j.ejrad.2012.01.035. View

Frusciante V, Niccoli Asabella A, Castriotta G, Guerra M, Murgo R, Ciuffreda L . [Added value of SPECT/CT over planar imaging in improving sentinel node detection in breast cancer patients]. Recenti Prog Med. 2016; 107(8):444-9. DOI: 10.1701/2332.25072. View

van der Ploeg I, Olmos R, Nieweg O, Rutgers E, Kroon B, Hoefnagel C . The additional value of SPECT/CT in lymphatic mapping in breast cancer and melanoma. J Nucl Med. 2007; 48(11):1756-60. DOI: 10.2967/jnumed.107.043372. View

Martinez A, Zerdoud S, Mery E, Bouissou E, Ferron G, Querleu D . Hybrid imaging by SPECT/CT for sentinel lymph node detection in patients with cancer of the uterine cervix. Gynecol Oncol. 2010; 119(3):431-5. DOI: 10.1016/j.ygyno.2010.08.001. View

Schrenk P, Rehberger W, Shamiyeh A, Wayand W . Sentinel node biopsy for breast cancer: does the number of sentinel nodes removed have an impact on the accuracy of finding a positive node?. J Surg Oncol. 2002; 80(3):130-6. DOI: 10.1002/jso.10112. View

Leijte J, van der Ploeg I, Olmos R, Nieweg O, Horenblas S . Visualization of tumor blockage and rerouting of lymphatic drainage in penile cancer patients by use of SPECT/CT. J Nucl Med. 2009; 50(3):364-7. DOI: 10.2967/jnumed.108.059733. View

10.

Lo Y, Hsueh S, Ma S, Chen S, Chen M . Clinical relevance of nonvisualized sentinel lymph nodes in unselected breast cancer patients during lymphoscintigraphy. Chang Gung Med J. 2005; 28(6):378-86. View

11.

van der Ploeg I, Olmos R, Kroon B, Nieweg O . The Hybrid SPECT/CT as an additional lymphatic mapping tool in patients with breast cancer. World J Surg. 2008; 32(9):1930-4. PMC: 2517087. DOI: 10.1007/s00268-008-9618-5. View

12.

Cox C, Dupont E, Whitehead G, Ebert M, Nguyen K, Peltz E . Age and body mass index may increase the chance of failure in sentinel lymph node biopsy for women with breast cancer. Breast J. 2002; 8(2):88-91. DOI: 10.1046/j.1524-4741.2002.08203.x. View

13.

Verheuvel N, Voogd A, Tjan-Heijnen V, Siesling S, Roumen R . Different outcome in node-positive breast cancer patients found by axillary ultrasound or sentinel node procedure. Breast Cancer Res Treat. 2017; 165(3):555-563. PMC: 5602026. DOI: 10.1007/s10549-017-4342-1. View

14.

Lerman H, Lievshitz G, Zak O, Metser U, Schneebaum S, Even-Sapir E . Improved sentinel node identification by SPECT/CT in overweight patients with breast cancer. J Nucl Med. 2007; 48(2):201-6. View

15.

Kroon B, Valdes Olmos R, Nieweg O, Horenblas S . Non-visualization of sentinel lymph nodes in penile carcinoma. Eur J Nucl Med Mol Imaging. 2005; 32(9):1096-9. DOI: 10.1007/s00259-005-1822-z. View

16.

Gallowitsch H, Kraschl P, Igerc I, Hussein T, Kresnik E, Mikosch P . Sentinel node SPECT-CT in breast cancer. Can we expect any additional and clinically relevant information?. Nuklearmedizin. 2007; 46(6):252-6. View

17.

Bennie G, Vorster M, Buscombe J, Sathekge M . The Added Value of a Single-photon Emission Computed Tomography-Computed Tomography in Sentinel Lymph Node Mapping in Patients with Breast Cancer and Malignant Melanoma. World J Nucl Med. 2015; 14(1):41-6. PMC: 4337007. DOI: 10.4103/1450-1147.150543. View

18.

Khokher S, Qureshi M, Riaz M, Akhtar N, Saleem A . Clinicopathologic profile of breast cancer patients in Pakistan: ten years data of a local cancer hospital. Asian Pac J Cancer Prev. 2012; 13(2):693-8. DOI: 10.7314/apjcp.2012.13.2.693. View

19.

Lerman H, Metser U, Lievshitz G, Sperber F, Shneebaum S, Even-Sapir E . Lymphoscintigraphic sentinel node identification in patients with breast cancer: the role of SPECT-CT. Eur J Nucl Med Mol Imaging. 2005; 33(3):329-37. DOI: 10.1007/s00259-005-1927-4. View

20.

Lyman G, Giuliano A, Somerfield M, Benson 3rd A, Bodurka D, Burstein H . American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005; 23(30):7703-20. DOI: 10.1200/JCO.2005.08.001. View